|
|
|
Insider
Information: |
Gross Phillip |
Relationship: |
10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
26 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
133,228,723 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$4,020,612,027 |
|
|
Total
Shares |
133,228,723 |
|
|
Total
Value |
$4,020,612,027 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
24
|
66
|
Stock
price went up :
|
8
|
10
|
Stock
price went down : |
16
|
56
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-3.8%
|
-765.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boulder Brands Inc |
BDBD |
10% Owner |
2007-09-07 |
0 |
2013-02-01 |
5,939,492 |
Premium* |
|
Hubbell Inc |
HUBB |
10% Owner |
|
0 |
2008-04-25 |
727,000 |
Premium* |
|
Pacific Sunwear Of California Inc |
PSUN |
10% Owner |
2008-07-11 |
0 |
2016-04-06 |
5,127,926 |
Premium* |
|
Sleep Number Corp |
SCSS |
See Remarks. |
|
0 |
2011-02-09 |
5,415,000 |
Premium* |
|
Celanese Corp |
CE |
10% Owner |
|
0 |
2009-02-02 |
13,588,774 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2009-03-04 |
0 |
2015-01-09 |
2,546,592 |
Premium* |
|
Correvio Pharma Corporation |
CORV |
10% Owner |
2009-04-09 |
0 |
2010-04-14 |
6,700,000 |
Premium* |
|
Mandalay Digital Group Inc |
MNDL |
10% Owner |
|
0 |
2012-03-01 |
10,053,333 |
Premium* |
|
Puma Biotechnology Inc |
PBYI |
10% Owner |
2012-04-26 |
0 |
2017-06-12 |
3,696,580 |
Premium* |
|
Concert Pharmaceuticals, Inc. |
CNCE |
10% Owner |
|
0 |
2014-02-20 |
510,147 |
Premium* |
|
HeartWare International Inc |
HTWR |
10% Owner |
|
0 |
2015-08-03 |
1,722,969 |
Premium* |
|
Calithera Biosciences, Inc. |
CALA |
10% Owner |
|
0 |
2017-09-28 |
3,546,873 |
Premium* |
|
Advaxis Inc |
ADXS |
10% Owner |
|
0 |
2017-10-11 |
4,100,043 |
Premium* |
|
Nexvet Biopharma Plc |
NVET |
10% Owner |
2014-02-10 |
0 |
2014-02-10 |
875,000 |
Premium* |
|
Five Prime Therapeutics Inc |
FPRX |
10% Owner |
|
0 |
2015-10-15 |
2,539,949 |
Premium* |
|
Vitae Pharmaceuticals, Inc |
VTAE |
10% Owner |
|
0 |
2016-09-14 |
2,375,000 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
2017-03-17 |
0 |
2017-03-17 |
675,000 |
Premium* |
|
Solaris Oilfield Infrastructure,... |
SOI |
10% Owner |
2017-05-12 |
0 |
2017-05-12 |
1,275,000 |
Premium* |
|
Protagonist Therapeutics, Inc |
PTGX |
10% Owner |
|
0 |
2017-05-30 |
2,056,076 |
Premium* |
|
Orbcomm Inc. |
ORBC |
10% Owner |
|
0 |
2020-08-12 |
7,697,220 |
Premium* |
|
Royalty Pharma Plc |
RPRX |
10% Owner |
2020-06-18 |
0 |
2020-12-18 |
38,714,280 |
Premium* |
|
Advent Technologies Holdings Ord... |
ADN |
10% Owner |
|
0 |
2020-12-03 |
781,535 |
Premium* |
|
Gcm Grosvenor Inc. |
GCMG |
10% Owner |
2021-05-18 |
0 |
2023-05-10 |
4,158,641 |
Premium* |
|
Abacus Life Ord Shs Class A |
ABL |
10% Owner |
|
0 |
2023-01-23 |
0 |
Premium* |
|
Abeona Therapeutics Inc |
ABEO |
10% Owner |
|
0 |
2023-07-03 |
3,249,994 |
Premium* |
|
EyePoint Pharmaceuticals Inc |
EYPT |
10% Owner |
|
0 |
2024-04-18 |
5,156,299 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
293 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ABL |
Abacus Life Ord Shs Class... |
10% Owner |
|
2022-07-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,348,214 |
|
% |
|
ABL |
Abacus Life Ord Shs Class... |
10% Owner |
|
2023-01-23 |
4 |
D |
$10.21 |
$23,975,265 |
I/I |
(2,348,214) |
0 |
0 |
- |
|
ABEO |
Abeona Therapeutics Inc |
10% Owner |
|
2023-07-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,249,994 |
|
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2014-12-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,454,604 |
|
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2015-02-18 |
4 |
B |
$7.50 |
$5,135,715 |
I/I |
684,762 |
5,139,366 |
1.5 |
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2015-04-30 |
4 |
B |
$19.00 |
$9,500,000 |
I/I |
500,000 |
5,639,366 |
1.5 |
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2015-08-20 |
4 |
B |
$14.17 |
$1,017,390 |
I/I |
71,182 |
5,814,366 |
1.5 |
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2015-08-20 |
4 |
B |
$14.28 |
$1,482,521 |
I/I |
103,818 |
5,743,184 |
1.5 |
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2015-08-21 |
4 |
B |
$14.21 |
$1,065,750 |
I/I |
75,000 |
5,889,366 |
1.5 |
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2015-08-24 |
4 |
B |
$12.90 |
$680,676 |
I/I |
50,000 |
5,939,366 |
1.5 |
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2017-09-22 |
4 |
S |
$4.68 |
$2,499,120 |
I/I |
(534,000) |
5,405,366 |
0 |
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2017-09-25 |
4 |
S |
$4.38 |
$1,775,315 |
I/I |
(405,323) |
5,000,043 |
0 |
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2017-09-26 |
4 |
S |
$4.00 |
$1,200,000 |
I/I |
(300,000) |
4,700,043 |
0 |
- |
|
ADXS |
Advaxis Inc |
10% Owner |
|
2017-10-11 |
4 |
S |
$4.30 |
$2,580,000 |
I/I |
(600,000) |
4,100,043 |
0 |
- |
|
ADN |
Advent Technologies Holdi... |
10% Owner |
|
2020-05-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,800,000 |
|
% |
|
ADN |
Advent Technologies Holdi... |
10% Owner |
|
2020-12-01 |
4 |
S |
$12.26 |
$5,517,000 |
I/I |
(450,000) |
1,350,000 |
0 |
% |
|
ADN |
Advent Technologies Holdi... |
10% Owner |
|
2020-12-02 |
4 |
S |
$11.67 |
$3,501,000 |
I/I |
(300,000) |
1,050,000 |
0 |
% |
|
ADN |
Advent Technologies Holdi... |
10% Owner |
|
2020-12-03 |
4 |
S |
$12.18 |
$3,269,904 |
I/I |
(268,465) |
781,535 |
0 |
% |
|
AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
|
2009-03-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,914,123 |
|
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
|
2009-03-04 |
4 |
B |
$26.64 |
$3,544,160 |
I/I |
133,061 |
2,047,184 |
1.5 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
|
2009-03-05 |
4 |
OE |
$34.84 |
$25,063,670 |
I/I |
577,324 |
2,047,184 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
|
2009-03-05 |
4 |
D |
$24.75 |
$14,288,769 |
I/I |
(577,324) |
1,569,860 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
|
2009-03-09 |
4 |
B |
$25.34 |
$1,516,880 |
I/I |
59,858 |
2,107,042 |
1.5 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
|
2009-03-11 |
4 |
B |
$25.58 |
$633,096 |
I/I |
24,751 |
2,131,793 |
1.5 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
|
2009-03-12 |
4 |
B |
$25.32 |
$279,220 |
I/I |
11,028 |
2,142,821 |
1.5 |
- |
|
293 Records found
|
|
Page 1 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|